Umeclidinium Bromide
Brand name: Incruse Ellipta
Rank #128 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$131.6M
Total Cost
290,677
Total Claims
$131.6M
Total Cost
11,376
Prescribers
$453
Cost per Claim
21,789
Beneficiaries
362,254
30-Day Fills
$12K
Avg Cost/Provider
26
Avg Claims/Provider
Share of Medicare Part D Spending
0.05%
of total Medicare Part D spending
$131.6M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $131.6M total
🔎 Data Overview
Average cost of $6,039 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Umeclidinium Bromide
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Mohammad-Ali El-Harakeh | Internal Medicine | Prescott, AZ | 566 | $288K |
| 2 | Jorge Sanchez-Masiques | Pulmonary Disease | Miami, FL | 643 | $251K |
| 3 | Misbahuddin Khaja | Pulmonary Disease | Bronx, NY | 421 | $180K |
| 4 | Sidharth Bagga | Internal Medicine | Oroville, CA | 404 | $174K |
| 5 | Jason Karp | Pulmonary Disease | Lake Success, NY | 227 | $173K |
| 6 | Edward Dimitry | Pulmonary Disease | Summit, NJ | 369 | $168K |
| 7 | Venkata Dodda | Pulmonary Disease | Bloomington, IL | 259 | $165K |
| 8 | Michael Netzel | Allergy/ Immunology | Monroe, WI | 295 | $153K |
| 9 | Jay Dobkin | Pulmonary Disease | Bronx, NY | 322 | $148K |
| 10 | Tyrone Lee | Pulmonary Disease | Conway, AR | 260 | $138K |
| 11 | Marie Cheryle Lingat | Pulmonary Disease | Hudson, NY | 294 | $135K |
| 12 | Chih Chen | Hospitalist | Springfield, MA | 331 | $135K |
| 13 | Anil Mattoo | Pulmonary Disease | Patchogue, NY | 154 | $132K |
| 14 | Jon Michel | Pulmonary Disease | Peoria, IL | 297 | $131K |
| 15 | Paul Weinstein | Pulmonary Disease | Scarsdale, NY | 268 | $131K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 125 | Buprenorphine Hcl/Naloxone Hcl (Buprenorphine-Naloxone) | $135.8M | 696,008 |
| 126 | Cenegermin-Bkbj (Oxervate) | $133.5M | 3,601 |
| 127 | Teriflunomide (Aubagio) | $131.9M | 18,010 |
| 128 | Umeclidinium Bromide (Incruse Ellipta) | $131.6M | 290,677 |
| 129 | Tiotropium Br/Olodaterol Hcl (Stiolto Respimat) | $130.3M | 201,233 |
| 130 | Immun Globg(Igg)/Malt/Iga Ov50 (Octagam) | $129.5M | 9,657 |
| 131 | Pregabalin (Pregabalin) | $124.3M | 2,696,923 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology